McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q1 2026 holdings
- Shares (Q1 2026)
- 30
- Value
- $5.81K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 30 | $5.81K | <0.1% | −1−1.6% | ReducedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 61 | $5.61K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 61 | $4.68K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 61 | $4.26K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 61 | $4.48K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 61 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 61 | $4.75K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 61 | $4.76K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 61 | $4.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 61 | $4.11K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 61 | $4.13K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 61 | $4.37K | <0.1% | −1,396−95.8% | Reduced | Holders |
| Q1 2023 | 1,457 | $101.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,457 | $98.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,457 | $80.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,457 | $96.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,457 | $97.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,457 | $85.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,457 | $88.0K | <0.1% | +1,169+405.9% | Added | Holders |
| Q2 2021 | 288 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 288 | $14.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.